A Phase 2 Study of Transarterial Chemoperfusion Treatment With Cisplatin, Methotrexate and Gemcitabine in Patients With Unresectable Pleural Mesothelioma
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin; Methotrexate
- Indications Mesothelioma
- Focus Therapeutic Use
- 28 Jul 2017 Planned End Date changed from 1 Feb 2018 to 1 Jun 2019.
- 28 Jul 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Jun 2018.
- 04 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.